March 17, 2025 Journal article Open Access

Molalign Aligaz Adisu

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <controlfield tag="005">20250905042025.0</controlfield>
  <controlfield tag="001">17252</controlfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">657808</subfield>
    <subfield code="z">md5:a7949531f99247051459d0db46e94b8a</subfield>
    <subfield code="u">https://zenodo.org/record/17252/files/Timeliness of the second dose of measles-containing vaccine uptake and its.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2025-03-17</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:17252</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Department of Pediatrics and Child Health Nursing, College of Medicine and Health Sciences, Woldia University, Woldia, Ethiopia</subfield>
    <subfield code="a">Molalign Aligaz Adisu</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Timeliness of the second dose of measles-containing vaccine uptake and its determinants among children aged 24–36 months in Gondar City, Northwest Ethiopia, 2023: Community-based cross-sectional study design</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by-nc/4.0/</subfield>
    <subfield code="a">Creative Commons Attribution-NonCommercial</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Background: Measles remains a global public health concern, despite the availability of effective vaccines. Recent&lt;br&gt;
outbreaks highlight the need for strong vaccination programs. Since launching both doses, Ethiopia has been&lt;br&gt;
working with global health organizations to increase vaccination coverage. However, focusing solely on coverage&lt;br&gt;
overlooks the importance of timely vaccination. In Ethiopia, despite occasional increases in coverage, measles&lt;br&gt;
outbreaks persist due to insufficient attention to timeliness. This study aims to assess the timeliness and its&lt;br&gt;
determinants of second-dose measles-containing vaccine uptake in Gondar City to inform efforts to strengthen&lt;br&gt;
immunization programs and prevent measles infections.&lt;br&gt;
Methods: A community-based cross-sectional study was conducted among 618 children aged 24&amp;ndash;36 months.&lt;br&gt;
Participants were selected using a two-stage systematic random sampling method from April 25 to May 25.&lt;br&gt;
Structured questionnaires were administered through interviews, and data were collected using the Kobo toolbox&lt;br&gt;
and then analyzed using Stata version 17. A binary logistic regression model was utilized to determine factors&lt;br&gt;
associated with the outcome, with significance declared at a p-value &amp;lt;0.05. Adjusted odds ratios with 95 %&lt;br&gt;
confidence intervals were used to assess the direction and strength of associations.&lt;br&gt;
Results: Among the total of 618 children, 523 (84.63 %) (95 % CI: 81.77 %&amp;ndash;87.48 %) were vaccinated for MCV2&lt;br&gt;
timely (in the national recommended age). Paternal college and above in their education (AOR: 5.84, 95 % CI:&lt;br&gt;
1.55&amp;ndash;8.18), four or more ANC follow-ups (AOR: 5.84, 95 % CI: 1.55&amp;ndash;8.18), at least two doses of vitamin An&lt;br&gt;
uptake (AOR: 6.39, 95 % CI: 2.92&amp;ndash;12.59), mothers having high awareness (AOR: 2.04, 95 % CI: 1.05&amp;ndash;3.99), and&lt;br&gt;
mothers having positive perception (AOR: 4.81, 95 % CI: 2.13&amp;ndash;10.86) to measles vaccination were significant&lt;br&gt;
determinants for timely uptake of the second dose measles-containing vaccine.&lt;br&gt;
Conclusion and recommendations: The timely uptake of the second dose of the measles vaccine in the study area&lt;br&gt;
was suboptimal, and efforts should be continued to eradicate measles infection. Paternal educational status, ANC&lt;br&gt;
follow-ups, repeated vitamin An uptake, maternal awareness, and perception of measles vaccination were statistically significant determinants for the timely uptake of a second dose of measles-containing vaccine.&lt;br&gt;
Strengthening maternal and child health services, increasing awareness, and changing mothers&amp;rsquo; perceptions&lt;br&gt;
about measles vaccination may increase the timely uptake of MCV2 among children receiving a second MCV&lt;br&gt;
dose.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.20372/nadre:17251</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.20372/nadre:17252</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>